Characteristics | Mediterranean diet score (MDS), basis of scoringa | |||||||
---|---|---|---|---|---|---|---|---|
The Mediterranean diet pyramid (PyrMDS) | Published literature (LitMDS) | Medians of dietary intake (mMDS) | Tertiles of dietary intake (tMDS) | |||||
Low | High | Low | High | Low | High | Low | High | |
n = 7898 | n = 7898 | n = 7730 | n = 8351 | n = 7903 | n = 6266 | n = 8927 | n = 8574 | |
Age (years) | 59.4 (9.4) | 58.2 (9.0)c | 58.8 (9.4) | 58.6 (9.1) | 59.2 (9.3) | 58.4 (9.1)c | 59.1 (9.3) | 58.7 (9.1)c |
Sex, men (%) | 56 | 32c | 58 | 32c | 44 | 45 | 46 | 42c |
Education level (%) | ||||||||
 School until age 16 years | 10 | 11 | 10 | 10 | 11 | 11 | 10 | 10 |
 School until age 18 years | 38 | 42 | 40 | 42 | 38 | 43 | 38 | 43 |
 Bachelor’s degree or above | 8 | 19c | 10 | 16c | 10 | 17c | 10 | 17c |
Marital status, married (%) | 84 | 79c | 83 | 80c | 80 | 83 | 81 | 82 |
Smoking status (%) | ||||||||
 Current | 16 | 8 | 17 | 8 | 16 | 7 | 15 | 8 |
 Former | 42 | 41c | 42 | 41c | 38 | 45c | 38 | 45c |
Physical activity level (%) | ||||||||
 Moderately inactive | 26 | 31 | 27 | 30 | 28 | 29 | 28 | 30 |
 Moderately active | 23 | 24 | 23 | 24 | 22 | 24 | 22 | 24 |
 Active | 19 | 19c | 19 | 19c | 17 | 22c | 17 | 20c |
Occupational status (%) | ||||||||
 Unskilled worker | 6 | 3 | 5 | 4 | 6 | 3 | 6 | 3 |
 Skilled worker | 63 | 52 | 60 | 54 | 61 | 53 | 61 | 51 |
 Manager or equivalent | 28 | 39 | 30 | 38 | 29 | 38 | 28 | 39 |
 Professional | 4 | 5c | 4 | 5c | 4 | 5c | 4 | 5c |
Family history of diabetes (%) | 13 | 13 | 13 | 13 | 13 | 14 | 13 | 13 |
Family history of MI (%) | 34 | 39c | 34 | 38c | 34 | 39c | 35 | 38c |
Family history of stroke (%) | 24 | 25 | 24 | 25 | 24 | 24 | 24 | 24 |
Season of FFQ administered (%) | ||||||||
 Spring | 27 | 27 | 26 | 28 | 26 | 27 | 27 | 27 |
 Summer | 24 | 26 | 24 | 26 | 25 | 26 | 25 | 25 |
 Autumn | 25 | 25b | 26 | 25 | 25 | 25 | 25 | 25 |
Prevalent diabetes (%) | 3 | 3 | 2 | 4c | 3 | 3b | 2 | 3c |
Use of anti-hypertensive drug (%) | 16 | 16 | 15 | 17c | 16 | 17 | 16 | 17b |
Use of lipid-lowering drug (%) | 1 | 1c | 1 | 2c | 1 | 2c | 1 | 2c |
Use of HRT among women (%) | 31 | 43c | 29 | 43c | 38 | 35c | 37 | 37c |
Body mass index, kg/m2 | 26.4 (3.8) | 26.1 (3.9) | 26.3 (3.7) | 26.2 (4.0) | 26.3 (4.0) | 26.3 (3.8) | 26.2 (3.9) | 26.2 (3.9) |
Waist circumference, cm | 90 (12) | 86 (12)c | 90 (12) | 86 (12)c | 88 (12) | 88 (12)c | 88 (12) | 87 (13)c |
Systolic BP, mmHg | 137 (18) | 133 (18)c | 136 (18) | 134 (19)c | 136 (18) | 135 (18)c | 136 (18) | 135 (19)c |
Diastolic BP, mmHg | 83 (11) | 81 (11)c | 83 (11) | 82 (11)c | 83 (11) | 82 (11)c | 83 (11) | 82 (11)c |
Total cholesterol, mmol/L | 6.2 (1.2) | 6.2 (1.2) | 6.2 (1.2) | 6.2 (1.2) | 6.2 (1.2) | 6.1 (1.1)c | 6.2 (1.2) | 6.2 (1.2) |
HDL cholesterol, mmol/L | 1.4 (0.4) | 1.5 (0.5)c | 1.4 (0.4) | 1.5 (0.4)c | 1.4 (0.4) | 1.5 (0.5)c | 1.4 (0.4) | 1.5 (0.5)c |
LDL cholesterol, mmol/L | 4.0 (1.0) | 3.9 (1.1)c | 4.0 (1.0) | 3.9 (1.1) | 4.0 (1.0) | 3.9 (1.0)c | 4.0 (1.0) | 3.9 (1.0)b |
Triglycerides, mmol/L | 1.9 (1.2) | 1.7 (1.0)c | 1.9 (1.1) | 1.7 (1.0)c | 1.8 (1.1) | 1.8 (1.1)c | 1.9 (1.1) | 1.7 (1.1)c |
QRISK2 score, %d | 19.4 (13.3) | 16.5 (12.4)c | 18.7 (13.1) | 17.3 (12.7)c | 18.8 (13.3) | 17.3 (12.7)c | 18.6 (13.1) | 17.6 (12.9)c |